Henderson et al. conducted a large and comprehensive prospective study over 10 years in patients with breast cancer and found that positive immunohistochemical staining for PTHrP in 79% of the primary tumors was associated with significantly improved survival and decreased bone metastasis (142). The gene discussed is PTHLH; the disease is breast cancer.